IP Verse

Public Eye opposition analysis

COMPANY ANALYSIS

Patent Number:

Title:

Use Of Chimeric Antigen Receptor-Modified T Cells To Treat Cancer

Applicant:

Opposition Date:

Jul 2, 2019

Patent Number	Title	Applicant	Opposition Date
EP3214091	Use Of Chimeric Antigen Receptor-Modified T Cells To Treat Cancer	THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA	Jul 2, 2019

THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA

Feel free to send us a message here and we will get back to you